Prevalence 2018 | Cost per item ($) | Base case cost ($) | Range ($) | ||
---|---|---|---|---|---|
Parameter | Number | Average cost (2018) | Base costs (2018) | (Lower (-25%) | Higher (+25) |
Direct costs (Health care costs) consultation fee | 90 | 41 | 3690 | 2768 | 4613 |
Screening and diagnosis | |||||
Prostate Specific Antigen (PSA) | 90 | 16 | 1448 | 1086 | 1810 |
Digital rectal examination (DRE) | 8 | 0 | 0 | 0 | 0 |
TRUS guided Biopsy | 90 | 147 | 13,213 | 9910 | 16,516 |
MRI scan | 90 | 1034 | 93,060 | 69,795 | 116,325 |
Chest x-ray | 90 | 28 | 2484 | 1863 | 3105 |
Bone scan | 90 | 607 | 54,630 | 40,973 | 68,288 |
Ultra sound | 90 | 103 | 9270 | 6953 | 11,588 |
CT scan abdomen | 90 | 862 | 77,580 | 58,185 | 96,975 |
Treatment | |||||
Stage I | 10 | 45,486 | 454,861 | 341,146 | 568,577 |
Stage II | 17 | 45,428 | 772,278 | 579,209 | 965,348 |
Stage III | 23 | 53,072 | 1,220,659 | 915,494 | 1,525,824 |
Stage IV | 40 | 53,072 | 2,122,886 | 1,592,164 | 2,653,607 |
Other direct costs | |||||
Hospitalization costs (local) | 90 | 210 | 18,900 | 14,175 | 23,625 |
Hospital admission in step down facility for late stage treatment | 90 | 1206 | 108,540 | 81,405 | 135,675 |
Transport and lodging cost (in RSA) | 90 | 5959 | 536,310 | 402,233 | 670,388 |
Follow-up care (Year 1 following completing treatment) | 60 | 2662 | 159,720 | 119,790 | 199,650 |
Total direct | 209,892 | 5,645,839 | 4,234,379 | 7,057,299 | |
Direct non-medical cost | |||||
Transport costs for follow-up visits ,patient | 59 | 2513 | 148,267 | 111,200 | 185,334 |
Transport costs for follow-up visits, accompanying relative | 59 | 2513 | 148,267 | 111,200 | 185,334 |
Total Direct non-medical costs | 5026 | 296,534 | 222,401 | 370,668 | |
Indirect costs | |||||
Morbidity costs due to sick leave | 13 | 648 | 8424 | 6318 | 10,530 |
Premature mortality costs | 4 | 57,675 | 230,700 | 173,025 | 288,375 |
Total indirect costs | 58,323 | 239,124 | 179,343 | 298,905 | |
Total | 268,215 | 6,181,497 | 4,636,123 | 7,726,871 |